Jump to main content
Jump to site search

Issue 3, 2014
Previous Article Next Article

A biomimic pH-sensitive polymeric prodrug based on polycarbonate for intracellular drug delivery

Author affiliations

Abstract

A biodegradable and endosomal pH-sensitive polymeric prodrug poly(5-methyl-5-allyloxycarbonyl-1,3-dioxan-2-one)-graft-12-acryloyloxy dodecyl phosphorylcholine-co-6-maleimidocaproyl-doxorubicin (PMAC-graft-(ADPC-co-Mal-DOX) was synthesized by ring-opening polymerization (ROP) and “click” reaction. DOX was conjugated to the polymer by hydrazone bonds which would result in a pH-sensitive controlled release of drug. The polymeric prodrug can form a self-assembled micellar structure which was confirmed by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Flow cytometry and fluorescence microscopy results demonstrated that prodrug micelles could be internalized by cancer cells remarkably. In vitro drug release studies showed that the release of DOX was faster at endosomal pH (pH = 5.0) than at normal physiological environment (pH = 7.4). Moreover, this prodrug exhibited high cytotoxicity against HepG2 cells and HeLa cells, indicating its great potential for cancer therapy.

Graphical abstract: A biomimic pH-sensitive polymeric prodrug based on polycarbonate for intracellular drug delivery

Back to tab navigation

Supplementary files

Article information


Submitted
02 Jul 2013
Accepted
06 Sep 2013
First published
09 Sep 2013

Polym. Chem., 2014,5, 854-861
Article type
Paper

A biomimic pH-sensitive polymeric prodrug based on polycarbonate for intracellular drug delivery

H. Wang, Y. Wang, Y. Chen, Q. Jin and J. Ji, Polym. Chem., 2014, 5, 854
DOI: 10.1039/C3PY00861D

Social activity

Search articles by author

Spotlight

Advertisements